Bioequivalence Study of Mesylate Imatinib Capsule in Chronic Myeloid Leukemia Body
Clinical trial NCT01795716 · COMPLETED
Trial details
- NCT number
- NCT01795716
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-01
- Primary completion
- 2013-06-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.